Skip to main content
. 2014 Oct 7;9(10):e109563. doi: 10.1371/journal.pone.0109563

Table 5. Association between patient characteristics and drug resistance patterns among PTB patients in tertiary care hospitals of Kolkata, India, 2010–2013 (N = 350).

Drug resistant status (ref:Susceptible)
Single drug resistance Non-MDR two drug resistance Multi-drug resistance (MDR)
Continuous Variables OR(95%Cl) p OR(95%Cl) p OR(95%Cl) p
Body mass index (kg/m2) UOR 0.83(0.59–1.16) 0.279 0.49(0.38–0.63) <.0001 0.44(0.31–0.63) <.0001
AOR 1.18(0.66–2.13) 0.572 0.73(0.46–1.15) 0.171 0.62(0.34–1.15) 0.130
Blood hemoglobin level (gm/dl) UOR 1.02(0.74–1.41) 0.896 1.38(1.08–1.75) 0.009 1.14(0.82–1.57) 0.435
AOR 0.92(0.61–1.39) 0.685 1.00(0.71–1.41) 0.994 0.71(0.45–1.13) 0.148
Categorical variables Single drug resistance Non-MDR two drug resistance Multi-drug resistance (MDR)
Variables Categories OR(95%Cl) p OR(95%Cl) p OR(95%Cl) p
Gender (ref: Male) Female UOR 0.82(0.34–1.97) 0.660 0.95(0.51–1.77) 0.885 0.80(0.33–1.90) 0.608
AOR 1.02(0.37–2.86) 0.965 1.43(0.63–3.27) 0.391 1.01(0.35–2.96) 0.981
Age(ref:<20 yr) 20–45 yr UOR 1.59(0.55–4.59) 0.390 2.22(1.07–4.62) 0.032 2.64(0.80–8.77) 0.111
AOR 1.64(0.30–8.86) 0.563 4.59(1.16–18.12) 0.030 7.30(1.10–48.59) 0.040
>45 yr UOR 5.00(1.08–23.06) 0.039 4.73(1.38–16.19) 0.013 7.45(1.47–38.27) 0.015
AOR 5.69(0.64–50.65) 0.119 12.14(1.82–80.92) 0.010 30.01(2.70–333.06) 0.006
Marital status (ref: Married) Unmarried UOR 0.68(0.27–1.71) 0.413 0.62(0.32–1.18) 0.144 0.57(0.22–1.47) 0.244
AOR 1.71(0.38–7.67) 0.483 4.16(1.20–14.48) 0.025 4.83(0.99–23.66) 0.052
SES (ref: LIG) MIG UOR 0.81(0.27–2.39) 0.704 0.58(0.26–1.28) 0.176 0.77(0.26–2.26) 0.630
AOR 0.47(0.13–1.67) 0.243 0.64(0.24–1.73) 0.382 0.92(0.25–3.35) 0.904
HIG UOR
AOR
Resident of (ref: Kolkata) North 24 Parganas UOR 3.86(0.67–22.35) 0.131 1.24(0.25–6.15) 0.792
AOR 5.37(0.69–41.42) 0.107 2.46(0.30–20.49) 0.405
South 24 Parganas UOR 3.48(1.07–11.33) 0.039 2.62(0.98–7.00) 0.054 1.47(0.4–5.44) 0.561
AOR 3.61(1.03–12.63) 0.044 3.54(1.14–10.91) 0.028 1.93(0.45–8.16) 0.374
Sputum smear grading (ref: Single positive) Double positive UOR 2.94(1.26–6.83) 0.012 1.03(0.57–1.85) 0.920 1.32(0.60–2.92) 0.491
AOR 2.52(0.87–7.35) 0.089 0.65(0.27–1.56) 0.338 0.90(0.29–2.83) 0.858
Triple positive UOR 2.83(0.36–22.39) 0.324 3.78(0.84–16.91) 0.082 1.70(0.22–13.02) 0.610
AOR 2.10(0.18–25.19) 0.557 2.41(0.34–16.99) 0.377 0.85(0.06–11.27) 0.904
X-ray(ref: Minimal) Moderately advanced UOR 1.27(0.50–3.27) 0.616 0.76(0.39–1.46) 0.405 0.56(0.22–1.40) 0.216
AOR 0.83(0.27–2.51) 0.738 0.27(0.11–0.67) 0.004 0.16(0.05–0.53) 0.003
Far advanced UOR 1.43(0.46–4.44) 0.534 0.67(0.29–1.53) 0.339 0.97(0.34–2.78) 0.958
AOR 0.58(0.14–2.44) 0.455 0.14(0.04–0.49) 0.002 0.14(0.03–0.68) 0.015
Cavity UOR 2.54(0.48–13.46) 0.272 2.12(0.58–7.75) 0.257 0.78(0.12–5.18) 0.795
AOR 0.78(0.11–5.96) 0.827 0.29(0.05–1.64) 0.161 0.11(0.01–1.17) 0.067
Patient type (ref: New Infection) Relapsed UOR 2.20(0.90–5.42) 0.084 9.97(4.83–20.58) <.0001 9.67(3.35–27.91) <.0001
AOR 3.01(0.62–15.35) 0.168 12.02(3.51–41.15) <.0001 13.84(2.55–75.06) 0.002
Defaulter UOR 1.15(0.25–5.24) 0.859 9.23(3.31–26.05) <.0001 10.06(2.55–39.69) 0.001
AOR 1.79(0.31–10.18) 0.510 16.87(4.77–59.69) <.0001 33.01(5.96–182.78) <.0001
Treatment failure UOR 1.91(0.11–32.00) 0.652 26.88(3.45–209.19) 0.002 50.28(5.42–465.91) 0.001
AOR 1.67(0.05–59.93) 0.780 31.86(2.66–381.62) 0.006 63.19(3.63–>99.99) 0.005

SES = Socio-economic status; LIG = Low-income group; MIG = Middle-income group; HIG = High-income group; UOR = Unadjusted Odds ratio; AOR = Adjusted Odds ratio; OR = Odds ratio; CI = Confidence interval; p = p value.

“–” refers to cells for which due to inadequate number of observation valid statistical results (OR, CI, p value) could not be determined